Amgen (AMGN) PT, Estimates Raised at Piper Jaffray Following 'Robust' Q2

July 30, 2014 9:07 AM

Piper Jaffray analyst Joshua Schimmer reiterated an Overweight rating and boosted his price target on Amgen (NASDAQ: AMGN) to $150.00 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found